Bradley C. Ekstrand

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial

Bradley C. Ekstrand, Jennifer B. Lucas, Steven M. Horwitz et al. · Blood · 2003 · 192 citations · Full text

Selection of Metalloporphyrin Heme Oxygenase Inhibitors Based on Potency and Photoreactivity

Hendrik J Verman, Bradley C. Ekstrand, David K. Stevenson · Pediatric Research · 1993 · 164 citations · Full text

Medicinal Chemistry, Photoredox Process, Photochemistry +12

Loss of DCC expression and glioma progression.

Miguel Reyes‐Múgica, Kimberly Rieger‐Christ, Hiroko Ohgaki et al. · PubMed · 1997 · 71 citations

Dcc Expression, Neuro-oncology, Oncology +12

DCC expression is altered by multiple mechanisms in brain tumours.

Bradley C. Ekstrand, Traci A. Mansfield, Sandra H. Bigner et al. · PubMed · 1995 · 46 citations

Phase II Trial of Bexarotene Capsules in Patients With Advanced Non–Small-Cell Lung Cancer After Failure of Two or More Previous Therapies

Ramaswamy Govindan, John Crowley, Lee S. Schwartzberg et al. · Journal of Clinical Oncology · 2006 · 30 citations · Full text